Metabolism of styrene in the human liver in vitro: interindividual variation and enantioselectivity

Abstract

1. The interindividual variation and enantioselectivity of the in vitro styrene oxidation by cytochrome P450 have been investigated in 20 human microsomal liver samples. Liver samples were genotyped for the CYP2E1*6 and CYP2E1*5B alleles. 2. Kinetic analysis indicated the presence of at least two forms of styrene-metabolizing cytochrome P450. The enzyme constants for the high-affinity component were subject to appreciable interindividual variation, i.e. V_max1 ranged from 0.39 to 3.20 nmol mg protein^-1 min^-1 (0.96±0.63) and K_m1 ranged from 0.005 to 0.03 mM (0.011±0.006). Inhibition studies with chemical inhibitors of CYP2E1,CYP1A2, CYP2C8/9 and CYP3A4 demonstrated that CYP2E1 was the primary enzyme involved in the high-affinity component of styrene oxidation. No relationship between the interindividual variation in V_max and K_m1 and the genetic polymorphisms of the CYP2E1 gene was found. 3. Cytochrome P450-mediated oxidation of styrene demonstrated a moderate enantioselectivity, with an enantiomeric excess (ee) of (S)-styrene oxide of 15% (range 4−27%) at low styrene concentration and an ee of (R)-styrene oxide of 7% (range − 11 to - 22%) at high styrene concentration.This points towards the involvement of at least two cytochrome P450, with different enantioselectivities. 4. The data indicate that cytochrome P450-mediated styrene oxidation is subject to considerable interindividual variation, but only to a moderate product enantioselectivity.